Characteristics of the CD8+ lymphocytosis during primary simian immunodeficiency virus infections

AIDS

Volumn 11, Issue 8, 1997, Pages 959-968

  Rosenberg, Yvonne J ^b   Cafaro, Aurelio ^a   Brennan, Terry ^a   Greenhouse, Jack G ^a   McKinnon, Kathy ^a   Bellah, Sharon ^a   Yalley Ogunro, Jacob ^a   Gartner, Suzanne ^a   Lewis, Mark G ^a  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b TherImmune Inc   (United States)

Author keywords

Acute infection; CD8 lymphocytosis; Simian immunodeficiency virus

Indexed keywords

CD28 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ILEUM; LUNG; LYMPH NODE; LYMPHOCYTOSIS; MACACA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SPLEEN; THYMUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD45; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LYMPHOCYTOSIS; MACACA FASCICULARIS; MACACA MULATTA; PREDICTIVE VALUE OF TESTS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

EID: 0030953748     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199708000-00003     Document Type: Article

References (52)

1. Vanham G, Kestens L, Penne G, et al.: Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol 1991, 11:345-356.
2. Reimann KA, Snyder GB, Chalifoux LV, et al.: An activated CD8+ lymphocyte appears in lymph nodes of rhesus monkeys early after infection with simian immunodeficiency virus. J Clin Invest 1991, 88:1113-1120.
3. Prince HE, Jensen ER: Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection. J Acquir Immune Defic Syndr 1991, 4:1227-1232.
4. Roos MTL, de Leeuw NASM, Claessen FAP, et al.: Viro-immunological studies in acute HIV-1 infection. AIDS 1994, 8:1533-1538.
5. Bensussan A, Rabian C, Schiavon V, et al.: Significant enlargement of a subset of CD3+CD8+ peripheral blood leukocytes mediating cytotoxic T-lymphocyte activity during human immunodeficiency virus infection. Proc Natl Acad Sci USA 1993, 90:9427-9430.
6. Borthwick NA, Bofill M, Gombert WM, et al.: Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS 1994, 8:431-441.
7. Caruso A, Cantalamessa A, Licenziati S, et al.: Expression of CD28 on CD8+ and CD4+ lymphocytes during HIV infection. Scand J Immunol 1994, 40:485-490.
8. Pantaleo G, Demarest JF, Soudeyns H, et al.: Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 1994, 370:463-467.
9. Luzuriaga K, McQuilken P, Alimenti A, et al.: Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection. J Infect Dis 1993, 167:1008-1013.
10. Azuma A, Phillips JH, Lanier L: CD28 lymphocytes. Antigenic and functional properties. J Immunol 1993, 150:1147-1159.
11. Saukkonen JJ, Kornfeld H, Berman JS: Expansion of a CD8+28-cell population in the blood and lung of HIV-positive patients. J Acquir Immune Defic Syndr 1993, 6:1194-1204.
12. Yasutomi Y, Reimann KA, Lord CI, et al.: Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol 1993, 67:1707-1711.
13. Ho HN, Hultin LE, Mitsuyasu RT, et al.: Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 1993, 150:3070-3079.
14. Oksenhendler E, Autran B, Gorochov G, et al.: CD8 lymphocytosis and pseudotumeral splenomegaly. Lancet 1992, 340:207-208.
15. Mackewicz CE, Ortega HW, Levy JA: CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991, 87:1462-1466.
16. Landay AL, Mackewicz CE, Levy JA: An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol 1993, 69:106-116.
17. Wang EC, Lehner PJ, Graham S, Borysiewicz LK: CD8 high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines. Eur J Immunol 1994, 24:2903-2909.
18. Sadat-Sowti B, Debre P, Mollet I, et al.: An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients. Eur J Immunol 1994, 24:2882-2888.
19. Joly P, Guillon JM, Mayaud C, et al.: Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol 1989, 143:2193-2201.
20. smmPBj14 infections of macaques. Virus Res 1994, 32:205-225.
21. smm/pbj) isolate from sooty mangabeys. AIDS Res Hum Retroviruses 1992, 8:1631-1639.
22. Tindall B, Cooper DA: Primary HIV infection: host responses and intervention and intervention strategies. AIDS 1991, 5:1-14.
23. Niu NT, Jermano JA, Reichelderfer P, Schnillman SM: Summary of the National Institutes of Health Workshop on primary human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1994, 9:913-924.
24. Rosenberg YJ, Zack PM, Leon EC, et al.: Immunological and virological changes associated with the decline in the CD4/CD8 ratios in lymphoid organs of SIV infected macaques. AIDS Res Hum Retroviruses 1994, 19:863-872.
25. Sanders ME, Makgoba MW, Shaw S: Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 1988, 9:195-199.
26. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994, 15:321-331.
27. Gross GG, Schwartz VL, Stevens C, et al.: Distribution of dominant T cell receptor b chains in human intestinal mucosa. J Exp Med 1994, 180:1337-1344.
28. Agostini C, Chilosi M, Zambello R, et al.: Pulmonary immune cells in health and disease: lymphocytes. Eur Respir J 1993, 6:1378-1401.
29. Rosenberg YJ, Cafaro A, Brennan T, et al.: Virus-induced cytokines regulate circulating lymphocyte levels during primary SIV infections. Inter Immunol 1997, 9 (in press).
30. Wang EC, Taylor-Wiedeman J, Perera P, et al.: Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with-human cytomegalovirus (HCMV) carrier status, phenotype and functional analysis. Clin Exp Immunol 1993, 94:297-305.
31. Choremi-Papadopoulou H, Viglis V, Gargalikanos P, et al.: Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J Acquir Immune Defic Syndr 1994, 7:245-253.
32. Giorgi JV: Phenotype and function of T cells in HIV disease. In Immunology of HIV Infection. Edited by Gupta S. New York: Plenum Press; 1996:181-199.
33. Poussier P, Julius M: Intestinal intraepithelial lymphocytes: the plot thickens. J Exp Med 1994, 180:1185-1189.
34. Erle DJ, Brown T, Christian D, Aris R: Lung epithelial lining fluid T cell subsets defined by distinct patterns of β7 and β1 integrin expression. Am J Respir Cell Mol Biol 1994, 10:237-244.
35. Parker CM, Cepek HL, Russell GJ, et al.: A family of β7 integrins on mucosal lymphocytes. Proc Natl Acad Sci USA 1992, 89:1924-1928.
36. Pedersen C, Lindhardt BO, Jensen BU: Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ 1989, 299:154-157.
37. Schechter MI, Craib KJP, Ie TN: Susceptibility to AIDS progression appears early in HIV infection. AIDS 1990, 4:185-190.
38. Rosenberg YJ, Zack PM, White BD, et al.: Decline in the CD4+ lymphocyte population in the blood of SIV-infected macaques is not reflected in the lymph node. AIDS Res Hum Retroviruses 1992, 9:639-646.
39. Lafeuillade A, Tamalet C, Pellegrino P, et al.: High viral burden in lymph nodes during early stages of HIV-1 infection [letter]. AIDS 1993, 7:1527-1528.
40. Saukkonen JJ, Kornfeld H, Berman JS: Expansion of a CD8+CD28- cell population in the blood and lung of HIV-positive patients. J Acquir Immune Defic Syndr 1993, 6:1194-1204.
41. Mackay CR: T cell memory: the connection between function, phenotype and migration pathways. Immunol Today 1991, 12:189-192.
42. low T cells in the human cord blood. J Immunol 1994, 152:5613-5623.
43. Malavasi F, Turano A, Alessio M, et al.: CD38: a multi-lineage cell activation molecule with a split personality. J Clin Lab Res 1992, 22:73-80.
44. Janossy G, Jiang JD, Roboz JP, et al.: Activated CD45RO, CD8+ T lymphocytes in HIV-1 infection. In Immunodeficiency in HIV Infection and AIDS. Edited by Jannosy G, Autran B, Miedema F. Basel: Karger; 1992:195-210.
45. smmPBj14 induces expression of a mucosal integrin on macaque lymphocytes. Virology 1996, 215:97-100.
46. smm/PBj-14 in pigtailed macaques. AIDS Res Hum Retroviruses 1993, 9:1123-1129.
47. Scala G, Ruocco MR, Ambrosino C, et al.: The expression of the Interleukin 6 gene is induced by the human immunodeficiency virus 1 Tat protein. J Exp Med 1994, 179:961-971.
48. Elson CO, Holland SP, Dertzbaugh MT, et al.: Morphological and functional alterations of mucosal T cells by cholera toxin and its B subunit. J Immunol 1995, 154:1032-1040.
49. Sadat-Sowti B, Parrot A, Quint L, et al.: Alveolar CD8+CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions. Am J Respir Crit Care Med 1994, 149:972-980.
50. Oksenhendler E, Gerrard L, Molina J-M, Ferchal F : Lymphocytosis in primary HIV infection is associated with CMV co-infection [letter]. AIDS 1993, 7:1023-1024.
51. Dobrescu D, Ursea B, Pope M, et al.: Enhanced HIV-1 replication in V beta 12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen. Cell 1995, 82:753-763.
52. Koup RA, Safrit JT, Cao Y, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994, 68:4650-4655.